TRIM2
Basic information
Region (hg38): 4:153152163-153339319
Links
Phenotypes
GenCC
Source:
- Charcot-Marie-Tooth disease type 2R (Limited), mode of inheritance: AR
- Charcot-Marie-Tooth disease type 2R (Supportive), mode of inheritance: AR
- Charcot-Marie-Tooth disease type 2R (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Charcot-Marie-Tooth disease, axonal, type 2R | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 23562820; 25893792 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRIM2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 146 | 157 | ||||
missense | 190 | 196 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 7 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 4 | 12 | 16 | |||
non coding | 52 | 18 | 75 | |||
Total | 0 | 2 | 211 | 202 | 24 |
Variants in TRIM2
This is a list of pathogenic ClinVar variants found in the TRIM2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-153204194-G-A | Likely benign (Aug 07, 2018) | |||
4-153204283-T-C | Benign (Jul 06, 2018) | |||
4-153204529-C-T | TRIM2-related disorder | Likely benign (May 24, 2019) | ||
4-153204530-G-GATGC | Likely pathogenic (Jul 01, 2016) | |||
4-153204556-C-T | not specified | Uncertain significance (Dec 16, 2023) | ||
4-153204846-T-C | Benign (Jul 05, 2018) | |||
4-153270074-G-A | Benign (Jul 15, 2018) | |||
4-153270118-C-T | Benign (Jul 31, 2018) | |||
4-153270129-T-C | Benign (Jul 15, 2018) | |||
4-153270361-C-T | TRIM2-related disorder | Likely benign (Jun 11, 2019) | ||
4-153270384-G-T | Uncertain significance (Dec 21, 2021) | |||
4-153270385-G-C | not specified | Uncertain significance (Jun 16, 2023) | ||
4-153270389-G-T | Charcot-Marie-Tooth disease type 2R | Uncertain significance (Oct 23, 2023) | ||
4-153270395-G-A | Charcot-Marie-Tooth disease type 2R | Uncertain significance (Apr 04, 2022) | ||
4-153270399-G-A | Charcot-Marie-Tooth disease type 2R | Uncertain significance (Mar 04, 2022) | ||
4-153270410-C-A | Charcot-Marie-Tooth disease type 2R | Uncertain significance (May 24, 2021) | ||
4-153270415-T-A | Charcot-Marie-Tooth disease type 2R | Uncertain significance (Jan 17, 2024) | ||
4-153270418-T-G | Charcot-Marie-Tooth disease type 2R | Likely benign (Mar 14, 2019) | ||
4-153270421-G-C | Charcot-Marie-Tooth disease type 2R • TRIM2-related disorder | Likely benign (Jun 22, 2023) | ||
4-153270423-T-C | Charcot-Marie-Tooth disease type 2R | Uncertain significance (Apr 18, 2023) | ||
4-153270425-C-T | Charcot-Marie-Tooth disease type 2R | Uncertain significance (Feb 25, 2023) | ||
4-153270426-G-A | Charcot-Marie-Tooth disease type 2R • TRIM2-related disorder | Likely benign (May 01, 2024) | ||
4-153270429-A-C | Charcot-Marie-Tooth disease type 2R | Uncertain significance (Mar 05, 2022) | ||
4-153270448-G-C | Charcot-Marie-Tooth disease type 2R | Likely benign (Oct 28, 2023) | ||
4-153270457-T-C | Charcot-Marie-Tooth disease type 2R | Likely benign (Jun 24, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRIM2 | protein_coding | protein_coding | ENST00000338700 | 12 | 186979 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.996 | 0.00397 | 125736 | 0 | 12 | 125748 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.57 | 248 | 465 | 0.534 | 0.0000277 | 5092 |
Missense in Polyphen | 58 | 156.07 | 0.37162 | 1720 | ||
Synonymous | 1.19 | 176 | 197 | 0.892 | 0.0000138 | 1515 |
Loss of Function | 4.76 | 4 | 34.0 | 0.118 | 0.00000194 | 372 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000869 | 0.0000869 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.0000548 | 0.0000544 |
Finnish | 0.0000464 | 0.0000462 |
European (Non-Finnish) | 0.0000354 | 0.0000352 |
Middle Eastern | 0.0000548 | 0.0000544 |
South Asian | 0.0000391 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: UBE2D1-dependent E3 ubiquitin-protein ligase that mediates the ubiquitination of NEFL and of phosphorylated BCL2L11. Plays a neuroprotective function. May play a role in neuronal rapid ischemic tolerance. {ECO:0000250|UniProtKB:Q9ESN6}.;
- Disease
- DISEASE: Charcot-Marie-Tooth disease 2R (CMT2R) [MIM:615490]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. {ECO:0000269|PubMed:23562820}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
(Consensus)
Recessive Scores
- pRec
- 0.102
Intolerance Scores
- loftool
- 0.266
- rvis_EVS
- -1.11
- rvis_percentile_EVS
- 6.78
Haploinsufficiency Scores
- pHI
- 0.654
- hipred
- Y
- hipred_score
- 0.724
- ghis
- 0.625
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.738
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trim2
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- trim2a
- Affected structure
- myeloid cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- protein polyubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;regulation of neuron apoptotic process
- Cellular component
- cytoplasm
- Molecular function
- ubiquitin-protein transferase activity;protein binding;zinc ion binding;ubiquitin protein ligase activity